Back
Brookfield Infrastructure Partners LP Vs. Kymera Therapeutics Industry Stock Comparison
Buy
61
BIP
Brookfield Infrastructure Partners LP
Last Price:
$33.99
Seasonality Move:
3.83%
Buy
70
KYMR
Kymera Therapeutics
Last Price:
$44.81
Seasonality Move:
20.91%
Buy
61
Brookfield Infrastructure Partners LP (BIP)
is a Buy
Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?
-
The current Brookfield Infrastructure Partners LP [BIP] share price is $34.07. The Score for BIP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIP Stock Price Chart
What is Brookfield Infrastructure Partners LP's stock price today?
-
The Brookfield Infrastructure Partners LP share price today is $34.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIP is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
BIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 64.37 | Buy |
Chaikin Money Flow: | 62245 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.93 - 33.71) | Buy |
Bollinger Bands (100): | (29.17 - 33.31) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 58.43 | Buy |
Chaikin Money Flow: | 47554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.09 - 49.29) | Buy |
Bollinger Bands (100): | (27.22 - 41.78) | Buy |
BIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.57 | Buy |
20-day SMA: | 33.34 | Buy |
50-day SMA: | 32.36 | Buy |
200-day SMA: | 32.42 | Buy |
8-day EMA: | 33.6 | Buy |
20-day EMA: | 33.29 | Buy |
50-day EMA: | 32.5 | Buy |
200-day EMA: | 31.78 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.11 | Sell |
20-day SMA: | 46.32 | Sell |
50-day SMA: | 38 | Buy |
200-day SMA: | 39.54 | Buy |
8-day EMA: | 44.94 | Sell |
20-day EMA: | 44.02 | Buy |
50-day EMA: | 39.8 | Buy |
200-day EMA: | 37.62 | Buy |
Brookfield Infrastructure Partners LP Earnings Growth & BIP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.72 per share, and an increase next year of $0.20 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.19 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.
Brookfield Infrastructure Partners LP Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |